GHK‑Cu 100mg | ≥99% Purity Research Peptide

GHK-Cu 100 mg is a high-purity lyophilized copper peptide research compound supplied exclusively for scientific investigation and controlled laboratory experimentation.

For research use only — not for human or veterinary use.

Product Overview

GHK-Cu is a copper-binding peptide complex widely investigated within peptide chemistry, molecular biology and biochemical research. It consists of the tripeptide GHK associated with copper and provides researchers with a defined molecular compound for controlled experimental investigation.

This preparation is labelled as containing 100 mg of lyophilized GHK-Cu. Independent third-party laboratory testing of this production batch measured an assay content of 96.5 mg, with chromatographic purity reported as greater than 99.8 percent.

The analytical identity of the tested material was evaluated through multiple complementary techniques. FTIR spectrum analysis produced an identification result of 987, HPLC retention time identification measured 0.997 and mass spectrometry identified a molecular ion mass of 341 Da.

In addition to assay, purity and identity verification, the production batch underwent bacterial endotoxin analysis, microbiological testing and comprehensive elemental impurity screening. This provides researchers with a substantially broader analytical profile than purity testing alone.

With independently verified analytical characteristics and complete batch-specific Certificate of Analysis documentation, GHK-Cu 100 mg provides a highly characterised research material for controlled scientific and laboratory investigation.

GHK-Cu Overview

GHK-Cu is a copper-associated tripeptide research compound consisting of the peptide sequence GHK complexed with copper. Its defined molecular characteristics have made it an established subject within peptide chemistry and molecular research.

Research involving GHK-Cu may focus on peptide-metal interactions, copper-binding chemistry, molecular signalling systems and other biochemical mechanisms associated with peptide complexes.

Because GHK-Cu combines a peptide structure with a metal ion, comprehensive analytical characterisation is particularly valuable. Researchers require information not only regarding chromatographic purity but also regarding compound identity, measured content and molecular characteristics.

For this reason, this production batch is independently evaluated using multiple analytical techniques rather than relying solely on a stated purity percentage.

Scientific and Research Context

Peptide-metal complexes represent an important area of biochemical research because interactions between peptides and metal ions can influence molecular structure, binding characteristics and biochemical behaviour.

GHK-Cu provides researchers with a defined copper peptide complex that can be investigated within carefully controlled experimental systems.

Modern analytical technologies have significantly improved the ability to characterise research compounds such as GHK-Cu. Chromatographic techniques allow assay content and purity to be evaluated, while FTIR spectrum analysis, retention time comparison and mass spectrometry provide additional information supporting compound identification.

Microbiological testing, bacterial endotoxin analysis and elemental impurity screening further expand the analytical profile beyond peptide-specific measurements.

This multi-parameter analytical approach is particularly valuable for research environments where reproducibility, traceability and transparent batch-specific documentation are important.

Mechanistic Focus in Research

Within controlled laboratory environments, GHK-Cu may be investigated as a defined copper peptide complex in experimental models involving peptide chemistry and molecular interactions.

Potential areas of scientific investigation include:

• Copper-peptide interaction studies
• Peptide-metal binding research
• Molecular interaction investigations
• Peptide signalling research
• Cellular pathway studies
• Biochemical regulatory pathway analysis
• Comparative peptide research
• Molecular biology investigations
• Controlled in vitro peptide experimentation

These areas describe scientific research contexts only and do not represent therapeutic, diagnostic or clinical applications.

Analytical Verification (COA)

This production batch of GHK-Cu 100 mg underwent independent third-party laboratory analysis by Liquilabs s.r.o. Czechia. The Certificate of Analysis provides batch-specific analytical information covering assay content, purity, identity, molecular ion mass, microbiological quality, bacterial endotoxin levels and elemental impurities.

Batch: GF-GHK100-B243

• Labelled Content: 100 mg
• Measured Assay Content: 96.5 mg
• Purity: greater than 99.8 percent
• FTIR Identification: 987
• HPLC Retention Time Identification: 0.997
• Molecular Ion Mass Identification: 341 Da
• Bacterial Endotoxins: 0.002 EU/mg
• Total Aerobic Microbial Count: 0 CFU/g
• Total Yeast and Mold Count: 0 CFU/g

These analytical measurements provide several independent parameters for evaluating the tested GHK-Cu material rather than relying on a single purity measurement.

Assay and Purity Verification

Assay content and chromatographic purity represent different analytical parameters and should be considered separately when evaluating a research compound.

Assay testing determines the measured quantity of the target compound within the analysed sample. For this GHK-Cu production batch, independent laboratory analysis measured an assay content of 96.5 mg against a labelled content of 100 mg.

Chromatographic purity analysis reported a result of greater than 99.8 percent.

A high chromatographic purity result does not itself determine the total quantity of material present in a vial. Reporting both assay content and purity therefore provides researchers with a more complete and transparent analytical profile of the tested production batch.

Identity Verification

Compound identity was evaluated using complementary analytical techniques rather than being inferred solely from chromatographic purity.

FTIR spectrum analysis produced a reported identification result of 987, while HPLC retention time identification measured 0.997.

These analytical measurements provide additional data points relating to the identity and characteristics of the tested GHK-Cu research material.

Mass Spectrometry Analysis

Mass spectrometry provides additional molecular information and forms another component of the identity assessment documented within the batch-specific Certificate of Analysis.

For this GHK-Cu production batch, molecular ion mass identification was reported at 341 Da.

Combining mass spectrometry with chromatographic and spectroscopic analysis provides a broader analytical characterisation than relying on any individual measurement alone.

Microbiological Testing

Microbiological analysis was performed as an additional component of the independent batch-specific quality assessment.

The analysed production batch produced the following results:

• Total Aerobic Microbial Count: 0 CFU/g
• Total Yeast and Mold Count: 0 CFU/g

No colony-forming units were reported for either of the microbiological parameters in the tested sample.

These results complement the compound-specific assay, purity and identity measurements and form part of the complete analytical profile of the production batch.

Bacterial Endotoxin Analysis

Bacterial endotoxin testing provides an additional analytical parameter for the characterisation of lyophilized research materials.

For this GHK-Cu 100 mg production batch, bacterial endotoxin analysis produced a measured result of 0.002 EU/mg.

The endotoxin result is documented alongside the microbiological, assay, purity and identity measurements within the independent Certificate of Analysis.

Including bacterial endotoxin analysis as part of the broader testing programme provides researchers with additional batch-specific analytical information concerning the tested research material.

Elemental Impurity Testing

Independent elemental impurity screening was performed as part of the comprehensive analytical programme for this production batch.

The tested elements included:

• Arsenic
• Cadmium
• Mercury
• Lead
• Nickel
• Vanadium
• Cobalt

Each of these tested elemental impurities was reported at less than 0.001 ppm.

Elemental impurity screening complements chromatographic purity, assay determination, identity verification, microbiological analysis and bacterial endotoxin testing to provide researchers with a broader analytical profile of the tested material.

Research Applications

GHK-Cu 100 mg is supplied for controlled scientific research and may be utilised as a defined copper peptide research compound within appropriate laboratory models.

Potential research contexts include:

• Copper peptide characterisation studies
• Peptide-metal interaction research
• Molecular binding investigations
• Peptide signalling studies
• Biochemical pathway research
• Comparative peptide analysis
• Molecular biology investigations
• Analytical peptide research
• Controlled in vitro studies

These applications relate exclusively to scientific experimentation and controlled laboratory research.

Comprehensive Batch Verification

Analytical quality cannot be represented by a purity percentage alone. Different analytical techniques evaluate different characteristics of a research material and collectively provide a more comprehensive understanding of the tested production batch.

Independent testing of this GHK-Cu batch includes:

• Assay content determination
• Chromatographic purity assessment
• FTIR spectrum identification
• HPLC retention time verification
• Molecular ion mass identification
• Bacterial endotoxin analysis
• Total Aerobic Microbial Count testing
• Total Yeast and Mold Count testing
• Elemental impurity screening
• Batch-specific analytical traceability

This multi-parameter approach provides researchers with significantly more analytical information than assay or purity testing alone.

Grail Formula Quality

Grail Formula places particular emphasis on independent third-party analytical verification, transparent batch documentation and measurable laboratory data.

Rather than relying solely on supplier specifications or unsupported purity statements, individual production batches are submitted for independent laboratory analysis to provide objective analytical information concerning the material supplied.

For this GHK-Cu 100 mg production batch, Liquilabs s.r.o. Czechia independently evaluated assay content, chromatographic purity, identity parameters, molecular ion mass, bacterial endotoxins, microbiological quality and elemental impurities.

The resulting Certificate of Analysis provides transparent batch-specific documentation that researchers can review when evaluating the analytical characteristics of the supplied research material.

When You Choose Grail Formula

When selecting Grail Formula, researchers receive research compounds supported by independent third-party analytical documentation and complete batch-specific traceability.

Our quality approach focuses on measurable laboratory results rather than relying solely on generic product specifications. For GHK-Cu 100 mg, independent analysis measured 96.5 mg assay content with purity greater than 99.8 percent.

Identity was further evaluated through FTIR spectrum analysis, HPLC retention time verification and molecular ion mass identification at 341 Da. The batch additionally underwent bacterial endotoxin, microbiological and elemental impurity testing.

The complete Certificate of Analysis allows researchers to review the underlying analytical results associated with the tested production batch directly.

Storage and Laboratory Handling

GHK-Cu 100 mg is supplied in lyophilized form for controlled laboratory research. Appropriate laboratory storage procedures should be followed to preserve the integrity of the research material.

The material should be handled only by qualified research personnel using established laboratory procedures appropriate for peptide and copper-peptide research compounds.

Any preparation or experimental handling should take place exclusively within a suitable controlled laboratory environment and in accordance with the requirements of the intended research protocol.

Research Use Limitation

• Intended solely for laboratory and in vitro research
• Not approved for human consumption
• Not approved for veterinary use
• Not intended for self-administration
• Not intended for diagnostic purposes
• Not intended for therapeutic applications
• Not intended to prevent or treat any disease
• Not permitted for clinical administration
• For research use only

GHK-Cu 100 mg is supplied exclusively as a research compound. All product information and analytical documentation are provided solely for scientific and laboratory purposes.

• Independently analysed by Liquilabs s.r.o. Czechia
• Greater than 99.8 % purity confirmed by independent analysis
• Assay content verified at 96.5 mg
• Identity confirmed by FTIR spectrum analysis
• FTIR identification result of 987
• HPLC retention time identification confirmed at 0.997
• Molecular ion mass identified at 341 Da by mass spectrometry
• Bacterial endotoxin level measured at 0.002 EU/mg
• Total Aerobic Microbial Count measured at 0 CFU/g
• Total Yeast and Mold Count measured at 0 CFU/g
• Arsenic, cadmium, mercury, lead, nickel, vanadium and cobalt all measured below 0.001 ppm
• Comprehensive batch-specific third-party analytical verification
• Research-grade lyophilized GHK-Cu compound
• Complete Certificate of Analysis traceability
• For research use only – not for human or veterinary use

For laboratory research only. Not intended for human consumption, injection, or cosmetic use.

This product is for research purposes only. Not for human use or diagnostic/therapeutic applications. Keep out of reach of children.